(THE CONVERSATION) The many controversial people appointed to the Trump administration, from Elon Musk to Robert F. Kennedy Jr., have at least one thing in common: They dislike and distrust experts.
Danaher on Wednesday missed Wall Street estimates for fourth-quarter profit due to soft demand for tools and services used in drug development by its biotech and pharmaceutical clients.
RFK Jr. played a lead role in building a case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, even if confirmed as health secretary.